日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis

特应性皮炎患者罹患炎症性肠病的风险

Chiesa Fuxench, Zelma C; Wan, Joy; Wang, Sonia; Syed, Maha N; Shin, Daniel B; Abuabara, Katrina; Gelfand, Joel M

Atopic dermatitis and risk of major neuropsychiatric disorders in children: A population-based cohort study

特应性皮炎与儿童罹患重大神经精神疾病的风险:一项基于人群的队列研究

Wan, Joy; Shin, Daniel B; Syed, Maha N; Abuabara, Katrina; Lemeshow, Adina R; Gelfand, Joel M

Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial.

阿普米司特与银屑病患者血管炎症和心血管代谢功能的关系:VIP-A 4 期开放标签非随机临床试验

Gelfand Joel M, Shin Daniel B, Armstrong April W, Tyring Stephen K, Blauvelt Andrew, Gottlieb Scott, Lockshin Benjamin N, Kalb Robert E, Fitzsimmons Robert, Rodante Justin, Parel Philip, Manyak Grigory A, Mendelsohn Laurel, Noe Megan H, Papadopoulos Maryte, Syed Maha N, Werner Thomas J, Wan Joy, Playford Martin P, Alavi Abass, Mehta Nehal N

Urticarial and Eczematous Eruptions Following mRNA COVID-19 Vaccination in Patients With and Without Chronic Urticaria and Atopic Dermatitis

接种mRNA COVID-19疫苗后,伴有或不伴有慢性荨麻疹和特应性皮炎的患者出现荨麻疹和湿疹样皮疹

Wan, Joy; Wang, Sonia; Shin, Daniel B; Syed, Maha N; Abuabara, Katrina; Lemeshow, Adina R; Gelfand, Joel M; Shah, Ruchi; Tsao, Lulu; Zheng, Jessica; Tang, Monica; Otani, Iris

Effect of anti-tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis-A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic

抗肿瘤坏死因子疗法对银屑病患者呼吸道感染及相关症状风险的影响——一项与 COVID-19 大流行期间决策相关的关键性 3 期试验的荟萃分析

Syed, Maha N; Shah, Mohsin; Shin, Daniel B; Wan, Marilyn T; Winthrop, Kevin L; Gelfand, Joel M

National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments

美国国家银屑病基金会 COVID-19 工作组关于疫情期间银屑病管理的指南:第二版——银屑病管理、COVID-19 疫苗和 COVID-19 治疗的进展

Gelfand, Joel M; Armstrong, April W; Bell, Stacie; Anesi, George L; Blauvelt, Andrew; Calabrese, Cassandra; Dommasch, Erica D; Feldman, Steven R; Gladman, Dafna; Kircik, Leon; Lebwohl, Mark; Lo Re, Vincent 3rd; Martin, George; Merola, Joseph F; Scher, Jose U; Schwartzman, Sergio; Treat, James R; Van Voorhees, Abby S; Ellebrecht, Christoph T; Fenner, Justine; Ocon, Anthony; Syed, Maha N; Weinstein, Erica J; Gondo, George; Heydon, Sue; Koons, Samantha; Ritchlin, Christopher T

The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic

接受白细胞介素 23 通路抑制生物制剂治疗的银屑病患者发生呼吸道感染的风险:一项与 COVID-19 大流行期间决策相关的关键性试验的荟萃分析

Syed, Maha N; Shin, Daniel B; Wan, Marilyn T; Winthrop, Kevin L; Gelfand, Joel M

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1

美国国家银屑病基金会 COVID-19 工作组关于疫情期间银屑病管理的指南:第一版

Gelfand, Joel M; Armstrong, April W; Bell, Stacie; Anesi, George L; Blauvelt, Andrew; Calabrese, Cassandra; Dommasch, Erica D; Feldman, Steve R; Gladman, Dafna; Kircik, Leon; Lebwohl, Mark; Lo Re, Vincent 3rd; Martin, George; Merola, Joseph F; Scher, Jose U; Schwartzman, Sergio; Treat, James R; Van Voorhees, Abby S; Ellebrecht, Christoph T; Fenner, Justine; Ocon, Anthony; Syed, Maha N; Weinstein, Erica J; Smith, Jessica; Gondo, George; Heydon, Sue; Koons, Samantha; Ritchlin, Christopher T

Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis

根据银屑病患者的社会人口学特征评估皮肤病生活质量指数中“不相关”回答的频率

Barbieri, John S; Shin, Daniel B; Syed, Maha N; Takeshita, Junko; Gelfand, Joel M